PolyNovo Limited (ASX:PNV)

Australia flag Australia · Delayed Price · Currency is AUD
1.950
+0.040 (2.09%)
Feb 21, 2025, 4:10 PM AEST
-2.50%
Market Cap 1.35B
Revenue (ttm) 103.23M
Net Income (ttm) 5.26M
Shares Out 690.84M
EPS (ttm) 0.01
PE Ratio 260.00
Forward PE 140.59
Dividend n/a
Ex-Dividend Date n/a
Volume 1,534,847
Average Volume 1,641,510
Open 1.940
Previous Close 1.910
Day's Range 1.900 - 1.975
52-Week Range 1.735 - 2.780
Beta 1.77
RSI 46.14
Earnings Date Feb 24, 2025

About PolyNovo

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal scaffold for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MT... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1998
Employees 254
Stock Exchange Australian Securities Exchange
Ticker Symbol PNV
Full Company Profile

Financial Performance

Financial Statements

News

Polynovo Ltd (CALZF) (Q4 2024) Earnings Call Transcript Highlights: Record Revenue and ...

Polynovo Ltd (CALZF) (Q4 2024) Earnings Call Transcript Highlights: Record Revenue and Strategic Growth

6 months ago - GuruFocus